logo

News

    • 28TH NOVEMBER 2025

    6 products re-classified as special containers from December 2025

    Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 December 2025. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose ampoules Teva UK Ltd 20 unit dose   

    Read more
    • 27TH NOVEMBER 2025

    November 2025 Price Concessions 5th Update

    The Department of Health and Social Care (DHSC) has today (27/11/2025) confirmed the following list of price concessions for November 2025: Drug Pack size Price concession Betamethasone 500microgram soluble tablets sugar free 100 £46.65 Cyclizine 50mg/1ml solution for injection ampoules 5 £3.80 Dexamethasone 500microgram tablets 28 £1.87 Fenofibrate micronised 67mg capsules 90 £8.69 Lansoprazole 30mg orodispersible tablets

    Read more
    • 27TH NOVEMBER 2025

    Class 4 Medicines Defect Notification: Baclofen 10mg Tablets (Special Concept Development UK Limited)

    MHRA Class 4 Medicines Defect Notification: Baclofen 10mg Tablets (Special Concept Development UK Limited) Drug alert number: EL(25)A/51 Date issued: 27 November 2025 Special Concept Development UK Limited has informed the MHRA that the Patient Information Leaflet (PIL) for the batches listed in this notification do not contain the correct safety information. DMRC reference number: DMRC –

    Read more
    • 27TH NOVEMBER 2025

    Use of ‘FS’ endorsement extended to Tuberculosis (TB) treatments

    From 1 December 2025, the use of the ‘FS’ prescriber endorsement has been extended to treatments used in the management of tuberculosis (TB) and latent TB infections, including the effects of TB and the adverse effects from TB treatment. Pharmacy teams should ensure that no prescription charge is levied for any items endorsed ‘FS’ by

    Read more
    • 26TH NOVEMBER 2025

    Chancellor delivers Budget speech

    The Chancellor announced her Budget in Parliament today (26th November), setting out the Government’s spending plans for the coming financial year. In terms of healthcare, the Budget commits £300 million of investment in technology to improve patient service and 250 new neighbourhood health centres. The Chancellor went on to say that the Government would be “expanding more

    Read more
© 2025 Middlesex Pharmaceutical Group